Could cheap heart drugs save lives from pesticide poisoning?

NCT ID NCT03925025

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether adding magnesium sulfate or nimodipine (drugs usually used for heart conditions) to standard treatment could help people who poisoned themselves with pesticides. Over 1,700 adults in medical wards were enrolled. The main goal was to see if these drugs reduced deaths before leaving the hospital.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Magnesium sulfate and nimodipine
What this could lead to
If effective, these cheap, widely available drugs could become a standard addition to current treatment, potentially saving many lives from pesticide poisoning.
What could go wrong
This is a completed Phase 3 trial, but results are not yet reported. The drugs may not improve survival over standard care, and side effects like low blood pressure are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTICHOLINESTERASE INSECTICIDE POISONING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chattogram Medical College Hospital

    Chittagong, 4203, Bangladesh

  • Jashore Medical College Hospital

    Jessore, Bangladesh

  • Khulna Medical College Hospital

    Khulna, Bangladesh

  • Rajshahi Medical College Hospital

    Rajshahi, Rajshahi Division, 6100, Bangladesh

  • Rangpur Medical College Hospital

    Rangpur City, Bangladesh

  • Shaheed Ziaur Rahman Medical College

    Bogra, Silimpur, 5800, Bangladesh

  • Sylhet MAG Osmani Medical College Hospital

    Sylhet, Bangladesh

More trials for these conditions

Other studies related to the condition(s) this trial covers.